EC Approved Pfizer’s HYMPAVZI™ (marstacimab) for Treatment of Adults and Adolescents with Severe Hemophilia
On Nov, 20, 2024, Pfizer announced that the European Commission (EC) has granted marketing authorization for HYMPAVZI™ (marstacimab)…
U.S. FDA Approved Pfizer’s HYMPAVZI™ (marstacimab-hncq) for Treatment of Adults and Adolescents with Hemophilia A or B
On Oct. 11, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved HYMPAVZI™ (marstacimab-hncq)…
U.S. FDA approved BioMarin’s ROCTAVIAN, the first and only gene therapy for adults with severe hemophilia A
On Jun. 29, 2023, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy…
Sanofi acquired Bioverativ for $11.6 billion
On Mar. 8, 2018, Sanofi acquired Waltham, Massachusetts-based Bioverativ for for $11.6 billion. Bioverativ’s extended half-life therapies, Eloctate…
Genentech drug Hemlibra (emicizumab-kxwh) was approved
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
Grifols opened state-of-the-art facility in Clayton to advance treatment of rare and life-threatening diseases
On Jun. 17, 2014, Grifols opened state-of-the-art North Fractionation Facility (NFF) in Clayton, NC, where production capacity of…
ZymoGenetics was instrumental in development of new hemophilia drug
On Mar. 27, 1999, Novo Nordisk, the ZymoGenetics parent company, announced approval of NovoSeven by the Food and…
Francisco Mojica characterized CRISPR
On Aug. 9, 1993, Francisco Mojica published “Transcription at different salinities of Haloferax mediterranei sequences adjacent to partially…
World Hemophilia Day was founded
On Apr. 17, 1989, World Hemophilia Day was started and the World Federation of Hemophilia (WFH) chose April…
President Ronald Reagan designated the month of March as Hemophilia Awareness Month
In 1986, President Ronald Reagan designated the month of March as Hemophilia Awareness Month to bring attention to…
Biotechnology | CDC | Diagnostics | HIV | Life Science News
The CDC received funding for HIV risk reduction services for people with hemophilia
On Jan. 4, 1983, epidemiologic evidence that the AIDS agent was blood-borne led to official meetings and public…